GANNON STEVEN

CIK 00016430852 companiesBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001643085

Recent Transactions

36 trades

Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-06-05$30.48/sh−3→ 7,141 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-06-05+2,645→ 2,645 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2025-05-14$12.57/sh+5,144→ 7,144 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2025-05-14−5,144→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−141,011→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−30,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Common Stock
2024-06-04−56,400→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$46.25/sh−5,000→ 9,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$46.30/sh−5,000→ 4,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$46.45/sh−1,000→ 14,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$46.20/sh−2,000→ 2,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2023-06-14+17,000→ 17,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Purchase
Fusion Pharmaceuticals Inc.
Common Stock
2022-08-11$2.03/sh+44,400→ 56,400 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2022-06-14+17,000→ 17,000 total
Purchase
Fusion Pharmaceuticals Inc.
Common Stock
2021-08-23$7.99/sh+2,829→ 12,000 total
Purchase
Fusion Pharmaceuticals Inc.
Common Stock
2021-08-19$8.05/sh+3,000→ 9,171 total
Purchase
Fusion Pharmaceuticals Inc.
Common Stock
2021-08-18$8.05/sh+171→ 6,171 total
Purchase
Fusion Pharmaceuticals Inc.
Common Stock
2021-08-16$8.10/sh+6,000→ 6,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2021-06-04+17,000→ 17,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-06-03+10,000→ 10,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-06-25+30,000→ 30,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-01-19+141,011→ 141,011 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+15,000→ 15,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-04+15,000→ 15,000 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-08-11$2.82/sh+15,000→ 15,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-06-01+3,500→ 3,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-06-02+3,500→ 3,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-05-21+5,144→ 5,144 total

Companies

Recent Filings

Address

3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov